Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

Share Price is delayed by 15 minutes
Get Live Data
88.50    0.00 (0.00%)
Bid:
87.00
Ask:
90.00
Spread: 3.00 (3.448%)
Market Cap: £59.37m
EAH Live PriceLast checked at - London Stock Exchange

Intraday Eco Animal Share Chart

Director/PDMR Shareholding

8 Feb 2023 07:00

RNS Number : 2200P
Eco Animal Health Group PLC
08 February 2023
Β 

Β 

ECO Animal Health Group plc

(''ECO" or the "Company") (AIM: EAH)

Β 

Director/PDMR Dealings

Β 

ECO Animal Health Group plc, a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, announces that on 7 February 2023, Tracey James, Non-executive Director, purchased 5,000 ordinary shares of 5 pence each ("Ordinary Shares") at a price of 90.0 pence per Ordinary Share.

Β 

Following this transaction, Tracey James' total interest in the Company is 5,000 Ordinary Shares representing less than 0.01 per cent. of the Company's total issued share capital.

Β 

Details of the transactions can be found in the Notification of Dealing Forms below.

Β 

For further information, please contact:

Β 

ECO Animal Health Group plc

David Hallas (CEO)

Christopher Wilks (CFO)

Β 

020 8447 8899

Β 

IFC Advisory

Graham Herring

Zach Cohen

Β 

020 3934 6630

Β 

Singer Capital Markets (Nominated Adviser & Joint Broker)

Phil Davies

George Tzimas

Β 

020 7496 3000

Investec (Joint Broker)

Gary Clarence

Daniel Adams

Carlo Spingardi

020 7597 5970

Β 

Β 

Β 

Equity Developments

Hannah Crowe

Matt Evans

020 7065 2692

Β 

Β 

About ECO Animal Health

ECO Animal Health Group plc researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products.

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

Tracey James

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

Non-executive Director

b)

Β 

Initial notification /Amendment

Β 

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

ECO Animal Health Group plc

b)

Β 

LEI

Β 

Β 

2138009XN9DJ3YP70B55

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

Β 

a)

Β 

Description of the financial instrument, type of instrument

Ordinary shares of 5 pence each

Β 

Identification code

GB0032036807Β 

b)

Β 

Nature of the transaction

Β 

Β 

Purchase of Ordinary Shares

c)

Β 

Price(s) and volume(s)

Price(s)

Volume(s)

90.0 pence

90.0 pence

Β 

3,000

2,000

d)

Β 

Aggregated information

Total volume of 5,000 shares at a price of 90.0 pence per Ordinary Share

- Aggregated volume

- Price

e)

Β 

Date of the transaction

Β 

Β 

7 February 2023

Β 

Β 

f)

Β 

Place of the transaction

Β 

Β 

London Stock Exchange, AIMX

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHBRGDDBDGDGXR
Date   Source Headline
28th Oct 20192:05 pmBUSHolding(s) in Company
28th Oct 20192:03 pmBUSHolding(s) in Company
19th Sep 20193:33 pmBUSResult of AGM
11th Sep 20197:00 amBUSStatement re ECO Animal Health and The Pirbright Institute sign second poultry vaccine development licencing deal.
4th Sep 20198:17 amBUSStatement re ECO Animal Health and The Pirbright Institute sign novel poultry biopharmaceutical development licencing deal
28th Aug 20198:12 amBUSPosting of AGM Notice - Replacement
27th Aug 20191:03 pmBUSCirc re. Posting of AGM Notice
22nd Aug 20197:00 amBUSDirectorate change
19th Aug 20197:00 amBUSDirectorate change
2nd Aug 20192:24 pmBUSHolding(s) in Company
2nd Aug 20191:12 pmBUSCirc re. Posting of Annual Report 2019
1st Aug 20192:17 pmBUSDirector/PDMR Shareholding
1st Aug 20197:00 amBUSBlock listing Interim Review
1st Aug 20197:00 amBUSTotal Voting Rights
8th Jul 20198:23 amBUSHolding(s) in Company
3rd Jul 20197:59 amBUSHolding(s) in Company
19th Jun 20197:00 amBUSFinal Results
5th Jun 201912:43 pmBUSHolding(s) in Company
29th May 20193:13 pmBUSDoc re. Change of Director Responsibilities
2nd Apr 20197:00 amBUSRegulatory Approval
20th Mar 20197:00 amBUSHolding(s) in Company
7th Mar 20197:05 amBUSDirector/PDMR Shareholding
7th Mar 20197:00 amBUSDirectorate change
5th Mar 20197:00 amBUSRegulatory Approval
13th Feb 20197:00 amBUSStatement Re ECO Animal Health and Ghent University Sign Poultry Vaccine Development Licencing Deal
7th Feb 201911:50 amBUSDirector/PDMR Shareholding
5th Feb 20199:58 amBUSHolding(s) in Company
5th Feb 20197:00 amBUSStatement re ECO Animal Health and University of Georgia sign second poultry vaccine development licencing deal
1st Feb 20197:00 amBUSBlock listing Interim Review
1st Feb 20197:00 amBUSTotal Voting Rights
31st Jan 201911:14 amBUSHolding(s) in Company
16th Jan 201910:48 amBUSDirector/PDMR Shareholding
27th Dec 20187:19 amBUSHolding(s) in Company
13th Dec 20183:00 pmBUSHolding(s) in Company
10th Dec 20187:00 amBUSHalf-year Report
5th Dec 201810:31 amBUSHolding(s) in Company
3rd Dec 20187:00 amBUSStatement re ECO Animal Health and Agrinnovation (Yissum) L.P. sign swine antimicrobial novel formulation development and licencing deal
27th Nov 20189:32 amBUSNotice of Results
19th Nov 20187:00 amBUSStatement re Joint poultry vaccine development licencing deal
7th Nov 20187:00 amBUSRegulatory Approval
1st Nov 20183:40 pmBUSHolding(s) in Company
1st Nov 20183:01 pmBUSHolding(s) in Company
26th Oct 20187:48 amBUSDirector/PDMR Shareholding
16th Oct 201811:26 amBUSHolding(s) in Company
20th Jul 20182:09 pmBUSDirector/PDMR Shareholding
18th Jul 201810:06 amBUSHolding(s) in Company
18th Jul 201810:01 amBUSHolding(s) in Company
10th Jul 20188:58 amBUSHolding(s) in Company
3rd Jul 20189:05 amBUSHolding(s) in Company
3rd Jul 20189:03 amBUSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.